Paratek
Kylie Pritchard, Pharm.D., BCPS - AQ ID, currently serves as the Medical Science Director at Paratek Pharmaceuticals since February 2024. Prior to this role, Kylie Pritchard was an Infectious Diseases Clinical Specialist at Accelerate Diagnostics from August 2018 to February 2024, and held a similar position at Swedish Medical Center from January 2014 to August 2018. Earlier experience includes serving as a Clinical Specialist in Infectious Diseases at Spartanburg Regional Healthcare System and as an Antimicrobial Stewardship Pharmacist at University of Toledo Physicians, LLC. Kylie Pritchard completed a PGY2 Infectious Diseases Pharmacy Residency and a PGY1 Pharmacy Residency at Clement J. Zablocki VA Medical Center. Education was received from Purdue University, culminating in a Doctor of Pharmacy degree in 2008.
This person is not in any teams
This person is not in any offices
Paratek
1 followers
Paratek Pharmaceuticals (NASDAQ: PRTK) is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments. We focus on drugs that target infec...